| Study |
Reference |
|
Anderson, 2020
|
Anderson Atypical antipsychotic use during pregnancy and birth defect risk: National Birth Defects Prevention Study, 1997-2011. Schizophr Res 2020; 215:81-88
|
|
Bellet - Aripiprazole, 2015
|
Bellet F Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study. Pharmacoepidemiol Drug Saf 2015;24:368-80
|
|
Boden - Olanzapine and/or clozapine, 2012
|
Boden R Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects. Arch Gen Psychiatry 2012;69:715-21
|
|
Bruno - Quetiapine, 2024
|
Bruno Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study. EClinicalMedicine 2024; 70:102531
|
|
Chan (Controls exposed to FGA), 2024
|
Chan Risk of congenital malformations associated with first-trimester exposure to antipsychotics: A propensity score-weighted population-based cohort study. Eur Psychiatry 2024; 67:e42
|
|
Chan (Controls unexposed, general pop), 2024
|
Chan Risk of congenital malformations associated with first-trimester exposure to antipsychotics: A propensity score-weighted population-based cohort study. Eur Psychiatry 2024; 67:e42
|
|
Chan (Controls unexposed, sick), 2024
|
Chan Risk of congenital malformations associated with first-trimester exposure to antipsychotics: A propensity score-weighted population-based cohort study. Eur Psychiatry 2024; 67:e42
|
|
Cohen, 2022
|
Cohen The National Pregnancy Registry for Psychiatric Medications: Effects of Fetal Exposure to Second-Generation Antipsychotics on Risk for Major Malformations. Neuropsychopharmacology 2022; 47:220-370 Cohen Reproductive Safety of Lurasidone and Quetiapine: Update from the National Pregnancy Registry for Psychiatric Medications. J Womens Health (Larchmt) 2023; : Cohen LS Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Am J Psychiatry 2016;173:263-70 Viguera Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. J Clin Psychiatry 2021; 82: Viguera Risk of Major Malformations Following First-Trimester Exposure to Olanzapine: Preliminary Data From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications. J Clin Psychopharmacol 2023; :
|
|
Ellfolk (Control exposed to FGA), 2019
|
Ellfolk Second-generation antipsychotics and pregnancy complications. Eur. J. Clin. Pharmacol. 2019; :
|
|
Ellfolk (Control unexposed), 2019
|
Ellfolk Second-generation antipsychotics and pregnancy complications. Eur. J. Clin. Pharmacol. 2019; :
|
|
Ellfolk (Controls exposed to FGA), 2021
|
Ellfolk Second-generation antipsychotics and pregnancy complications. Eur. J. Clin. Pharmacol. 2019; : Ellfolk Second-generation antipsychotic use during pregnancy and risk of congenital malformations. Eur J Clin Pharmacol 2021; 77:1737-1745
|
|
Ellfolk (Controls unexposed, NOS), 2021
|
Ellfolk Second-generation antipsychotics and pregnancy complications. Eur. J. Clin. Pharmacol. 2019; : Ellfolk Second-generation antipsychotic use during pregnancy and risk of congenital malformations. Eur J Clin Pharmacol 2021; 77:1737-1745
|
|
Frayne (Control exposed to antidepressants), 2018
|
Frayne J The Relationship Between Pregnancy Exposure to Antidepressant and Atypical Antipsychotic Medications and Placental Weight and Birth Weight Ratio: A Retrospective Cohort Study. J Clin Psychopharmacol 2018;38:563-569
|
|
Frayne (Control unexposed, sick), 2018
|
Frayne J The Relationship Between Pregnancy Exposure to Antidepressant and Atypical Antipsychotic Medications and Placental Weight and Birth Weight Ratio: A Retrospective Cohort Study. J Clin Psychopharmacol 2018;38:563-569
|
|
Habermann (Control exposed to FGA), 2013
|
Habermann F Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol 2013;33:453-62
|
|
Habermann (Control unexposed, disease free), 2013
|
Habermann F Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol 2013;33:453-62
|
|
Halfdanarson (Controls exposed to FGA), 2022
|
Halfdanarson Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study. Evid Based Ment Health 2022; 25:54-62
|
|
Halfdanarson (Controls unexposed, NOS), 2022
|
Halfdanarson Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study. Evid Based Ment Health 2022; 25:54-62
|
|
Heinonen a (Controls unexposed, NOS), 2022
|
Heinonen Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden. CNS Drugs 2022; :
|
|
Heinonen a (Controls unexposed, sick), 2022
|
Heinonen Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden. CNS Drugs 2022; :
|
|
Heinonen b (Controls exposed to FGA), 2022
|
Heinonen Neonatal morbidity after fetal exposure to antipsychotics: a national register-based study. BMJ Open 2022; 12:e061328
|
|
Heinonen b (Controls unexposed, NOS), 2022
|
Heinonen Neonatal morbidity after fetal exposure to antipsychotics: a national register-based study. BMJ Open 2022; 12:e061328
|
|
Heinonen b (Controls unexposed, sick), 2022
|
Heinonen Neonatal morbidity after fetal exposure to antipsychotics: a national register-based study. BMJ Open 2022; 12:e061328
|
|
Hironaka (Control exposed to BZD), 2011
|
Hironaka M Maternal mental disorders and pregnancy outcomes: a clinical study in a Japanese population. J Obstet Gynaecol Res 2011;37:1283-9
|
|
Hironaka (Control unexposed, disease free), 2011
|
Hironaka M Maternal mental disorders and pregnancy outcomes: a clinical study in a Japanese population. J Obstet Gynaecol Res 2011;37:1283-9
|
|
Hironaka (Control unexposed, sick), 2011
|
Hironaka M Maternal mental disorders and pregnancy outcomes: a clinical study in a Japanese population. J Obstet Gynaecol Res 2011;37:1283-9
|
|
Huybrechts (Controls unexposed, NOS), 2023
|
Huybrechts The impact of in-utero antipsychotic drug exposure on congenital malformations: An international cohort study Pharmacoepidemiol Drug Saf 2021; 30 Suppl 1:3-439 Huybrechts Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US. JAMA Psychiatry 2023; 80:156-166 Huybrechts Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry 2016; 73:938-46 Liu Maternal antipsychotic use during pregnancy and congenital malformations. Am J Obstet Gynecol MFM 2023; 5:100950
|
|
Huybrechts (Controls unexposed, sick), 2023
|
Huybrechts The impact of in-utero antipsychotic drug exposure on congenital malformations: An international cohort study Pharmacoepidemiol Drug Saf 2021; 30 Suppl 1:3-439 Huybrechts Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US. JAMA Psychiatry 2023; 80:156-166 Huybrechts Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry 2016; 73:938-46 Liu Maternal antipsychotic use during pregnancy and congenital malformations. Am J Obstet Gynecol MFM 2023; 5:100950
|
|
Ishikawa, 2024
|
Ishikawa Association between exposure to atypical antipsychotics during pregnancy and risk of miscarriage. Acta Psychiatr Scand 2024; 150:562-572
|
|
Källen, 2013
|
Källen B The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel) 2013;6:1221-86
|
|
Kananen - Quetiapine, 2023
|
Kananen Quetiapine and other antipsychotic medications during pregnancy: a 15-year follow-up of a university hospital birth register. Nord J Psychiatry 2023; 77:651-660
|
|
Kernizan, 2019
|
Kernizan, N. Evaluation of mood stabilizers on neonatal outcomes during pregnancy JACCP J.Am. Coll. Clin. Pharm. 2019; 2:569-.
|
|
Kernizan (Controls exposed to LTG), 2024
|
Kernizan Mood stabilizers for treatment of bipolar disorder in pregnancy and impact on neonatal outcomes. Bipolar Disord 2024; 26:779-784
|
|
Kernizan (Controls unexposed, sick), 2024
|
Kernizan Mood stabilizers for treatment of bipolar disorder in pregnancy and impact on neonatal outcomes. Bipolar Disord 2024; 26:779-784
|
|
Kulkarni - Quetiapine, 2024
|
Kulkarni Clozapine Safety in Pregnancy: A Clinical Study. Schizophr Bull 2024; :
|
|
Lin (Control exposed to FGA), 2010
|
Lin HC Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res 2010;116:55-60
|
|
Lin (Control unexposed, disease free), 2010
|
Lin HC Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res 2010;116:55-60
|
|
Lin (Control unexposed, sick), 2010
|
Lin HC Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res 2010;116:55-60
|
|
McKenna, 2005
|
McKenna K Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 2005;66:444-9; quiz 546
|
|
Newham (Control exposed to FGA), 2008
|
Newham JJ Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry 2008;192:333-7
|
|
Newham (Control unexposed, disease free), 2008
|
Newham JJ Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry 2008;192:333-7
|
|
Newport, 2007
|
Newport DJ Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry 2007;164:1214-20
|
|
Ozturk, 2016
|
Ozturk Z Safety of psychotropic medications in pregnancy: An observational cohort study Klinik Psikofarmakoloji Bulteni 2016; 26:229-237.
|
|
Panchaud, 2017
|
Panchaud A Use of atypical antipsychotics in pregnancy and maternal gestational diabetes. J Psychiatr Res 2017;95:84-90
|
|
Park, 2018
|
Park Y Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. Am J Psychiatry. 2018 Jun 1;175(6):564-574
|
|
Paulus, 2005
|
Paulus W Atypical antipsychotic agents in early pregnancy Reprod Toxicol 2005;20:453–491
|
|
Paulus - Aripiprazole only, 2013
|
Paulus Is the use of aripiprazole safe during first trimester of pregnancy? Reproductive Toxicology 2013;37:87.
|
|
Peng, 2013
|
Peng M Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study. Psychopharmacology (Berl) 2013;228:577-84
|
|
Petersen (Control discontinued treatment before pregnancy), 2016
|
Petersen I Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records. Schizophr Res 2016;176:349-356 Petersen I Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. Health Technol Assess 2016;20:1-176
|
|
Petersen (Control exposed to FGA), 2016
|
Petersen I Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records. Schizophr Res 2016;176:349-356 Petersen I Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. Health Technol Assess 2016;20:1-176
|
|
Petersen (Control unexposed, disease free), 2016
|
Petersen I Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records. Schizophr Res 2016;176:349-356 Petersen I Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. Health Technol Assess 2016;20:1-176
|
|
Raguideau, 2017
|
Raguideau F Exposition in utero à l'acide valproïque et aux autres traitements de l'épilepsie et des troubles bipolaires et risque de malformations congénitales majeures (MCM) en France Agence nationale de sécurité du médicament et des produits de santé 2015:1-116
|
|
Reis (Control exposed to FGA), 2008
|
Reis M Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 2008;28:279-88
|
|
Reis (Control unexposed, NOS), 2008
|
Reis M Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 2008;28:279-88
|
|
Sadowski, 2013
|
Sadowski A Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. BMJ Open 2013;3:
|
|
Schaffer (Controls unexposed, NOS), 2019
|
Schaffer Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics. Aust N Z J Psychiatry 2019; 53:1208-1221
|
|
Schaffer (Controls unexposed, sick), 2019
|
Schaffer Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics. Aust N Z J Psychiatry 2019; 53:1208-1221
|
|
Sorensen - Olanzapine, 2015
|
Sorensen MJ Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy. PLoS One 2015;10:e0132280
|
|
Straub, 2022
|
Straub Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders: A National Birth Cohort Study. JAMA Intern Med 2022; 182:522-533
|
|
Sutter-Dallay, 2015
|
Sutter-Dallay AL Impact of prenatal exposure to psychotropic drugs on neonatal outcome in infants of mothers with serious psychiatric illnesses. J Clin Psychiatry 2015;76:967-73
|
|
Swetlik, 2024
|
Swetlik Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior Among Preschool-Aged Children: Preliminary Results From the National Pregnancy Registry for Psychiatric Medications. J Clin Psychiatry 2024; 85:
|
|
Vial (Control exposed to FGA), 2009
|
Vial T Pregnancy Outcome in Women Exposed to Atypical Antipsychotics Drug Saf 2009;32:933-934
|
|
Vial (Control unexposed, NOS), 2009
|
Vial T Pregnancy Outcome in Women Exposed to Atypical Antipsychotics Drug Saf 2009;32:933-934
|
|
Vigod, 2015
|
Vigod SN Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ 2015;350:h2298
|
|
Viguera b, 2023
|
Viguera Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications. J Clin Psychiatry 2023; 84:
|
|
Wang a (Controls exposed to FGA), 2021
|
Wang Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age. JAMA Intern Med 2021; 181:1332-1340
|
|
Wang a (Controls unexposed, NOS), 2021
|
Wang Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age. JAMA Intern Med 2021; 181:1332-1340
|
|
Wang b - HK cohort, 2021
|
Wang Association between antipsychotic use in pregnancy and the risk of gestational diabetes: Population-based cohort studies from the United Kingdom and Hong Kong and an updated meta-analysis. Schizophr Res 2021; 229:55-62
|
|
Wang b - UK cohort, 2021
|
Wang Association between antipsychotic use in pregnancy and the risk of gestational diabetes: Population-based cohort studies from the United Kingdom and Hong Kong and an updated meta-analysis. Schizophr Res 2021; 229:55-62
|
|
Wurtz, 2017
|
Wurtz AML Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark. Clin Epidemiol 2017;9:657-666
|
|
Yakuwa, 2019
|
Yakuwa Second-Generation Antipsychotic Drugs Use in First-Trimester and the Risk for Major Malformations: A Prospective Cohort Study from Japan Drug Information Institute in Pregnancy Birth Defects Research 2019; 111:556–560
|
|
Yaris, 2005
|
Yaris Psychotropic drugs in pregnancy: a case-control study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29:333-8
|
|
Yeh, 2021
|
Yeh Bipolar women's antepartum psychotropic exposure and offspring risk of attention-deficit/hyperactivity disorder and autism spectrum disorder. J Affect Disord 2021; 295:1407-1414
|
